ANDA 76249, held by Impax Labs. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 76249 (Metformin Hydrochloride), held by Impax Labs, was first approved by FDA on Jul 30, 2004, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 30, 2004 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metformin Hydrochloride500MG · tablet, extended release;oral | Metformin Hydrochloride | Discontinued |
| Aug 11, 2026 | Supplement 6Labeling · Standard review | Approved | None posted |
| Jul 22, 2026 | Supplement 2Labeling · Standard review | Approved | None posted |
| Jul 22, 2026 | Supplement 4Labeling · Standard review | Approved | None posted |
| Jul 30, 2004 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters